
The Princess Máxima Center for Pediatric Oncology in Utrecht, The Netherlands, is hosting an exclusive Preceptorship on “New Developments in Specific Risk Groups of Acute Lymphoblastic Leukemia” on May 19 & 20, 2025. This highly interactive, in-person meeting provides a unique learning opportunity for pediatric oncologists, hematologists, and other experts in the field.
Why Attend?
- Gain insights into new treatment strategies for specific molecular and immunological sub-groups of ALL.
- Learn about approaches to reduce toxicity and improve patient outcomes.
- Engage in practical, case-based discussions with leading Dutch and international faculty.
- Benefit from a small-group setting that encourages direct interaction with experts.
- Earn CME accreditation from EACCME®.
Who Should Attend?
This preceptorship is designed for pediatric oncologists and hematologists, whether in training or already practicing, as well as other professionals involved in the treatment of childhood leukemia.
Register Now
Seats are limited to ensure meaningful interaction. For more details and registration, visit:
Home | Preceptorship meeting (prinsesmaximacentrum-events.nl)
Don’t miss this opportunity to expand your knowledge and network with global leaders in pediatric oncology!